Translate Bio (TBIO) - Market capitalization

Last known market cap: NZ$4.81 Billion

As of November 2024 Translate Bio has a market cap of NZ$4.81 Billion. This makes Translate Bio the world's 3674th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Translate Bio in

End of year Market Cap

Year	Marketcap	Change

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Agilent Technologies A	NZ$62.23 B	1,192.91%	🇺🇸 USA
Illumina ILMN	NZ$36.50 B	658.48%	🇺🇸 USA
Thermo Fisher Scientific TMO	NZ$334.51 B	6,849.67%	🇺🇸 USA
PerkinElmer PKI	NZ$24.63 B	411.91%	🇺🇸 USA
Bio-Rad Laboratories BIO	NZ$15.16 B	215.03%	🇺🇸 USA
Quest Diagnostics DGX	NZ$30.52 B	534.14%	🇺🇸 USA
General Electric GE	NZ$326.39 B	6,680.99%	🇺🇸 USA
LabCorp LH	NZ$33.53 B	596.65%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Translate Bio (TBIO.defunct)

Last known market cap: NZ$4.81 Billion